共 50 条
- [31] XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3aCANCER LETTERS, 2021, 503 : 197 - 212Wang, JingyaSun, TaoMeng, ZhaotingWang, LiuchunLi, MengjieChen, JinliangQin, TingtingYu, JiangyongZhang, MiaoBie, ZhixinDong, ZhiqiangJiang, XiangliLi LinZhang, CuicuiLiu, ZhujunJiang, RichengYang, GuangLi, LinZhang, YanHuang, Dingzhi
- [32] XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκBMOLECULAR CANCER THERAPEUTICS, 2018, 17 (12) : 2564 - 2574Ming, MeiWu, WenjunXie, BingqingSukhanova, MadinaWang, WeigeKadri, SabahSharma, ShrutiLee, JimmyShacham, SharonLandesman, YosefMaltsev, NataliaLu, PinWang, Y. Lynn
- [33] Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphomaAMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : 923 - 930Jardin, FabricePujals, AnaisPelletier, LauraBohers, ElodieCamus, VincentMareschal, SylvainDubois, SydneySola, BrigitteOchmann, MarleneLemonnier, FrancoisViailly, Pierre-JulienBertrand, PhilippeMaingonnat, CatherineTraverse-Glehen, AlexandraGaulard, PhilippeDamotte, DianeDelarue, RichardHaioun, CorinneArgueta, ChristianLandesman, YosefSalles, GillesJais, Jean-PhilippeFigeac, MartinCopie-Bergman, ChristianeMolina, Thierry JoPicquenot, Jean MichelCornic, MarieFest, ThierryMilpied, NoelLemasle, EmilieStamatoullas, AspasiaMoeller, PeterDyer, Martin J. S.Sundstrom, ChristerBastard, ChristianTilly, HerveLeroy, Karen
- [34] A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with EVA (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1CELLS, 2024, 13 (07)Zhao, KaiBraun, MaditaMeyer, LeonieOtte, KatharinaRaifer, HartmannHelmprobst, FrederikMoeschl, VincentPagenstecher, AxelUrban, HansRonellenfitsch, Michael W.Steinbach, Joachim P.Pesek, JelenaWatzer, BernhardNockher, Wolfgang A.Taudte, R. VerenaNeubauer, AndreasNimsky, ChristopherBartsch, Joerg W.Rusch, Tillmann
- [35] A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemiaINTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : 683 - 692Chauzeix, JasminePastoret, CedricDonaty, LucieGachard, NathalieFest, ThierryFeuillard, JeanRizzo, David
- [36] GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignanciesMOLECULAR CELL, 2024, 84 (10) : 1886 - 1903.e10Benbarche, SalimaPineda, Jose Mario BelloGalvis, Laura BaqueroBiswas, JeetayuLiu, BoWang, EricZhang, QianHogg, Simon J.Lyttle, KadeenDahi, ArianaLewis, Alexander M.Saechi, MartinaRahman, JahanFox, NinaAi, YuxiMehta, SanjoyGarippa, RalphOrtiz-Pacheco, JulianaLi, ZhuoningMonetti, MaraStanley, Robert F.Doulatov, SergeiBradley, Robert K.Abdel-Wahab, Omar
- [38] Effect of XPO1 inhibition in cancer cells on the 3D nuclear organization of telomeres: Quantitative analysis of short-term effectsJOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Lichtensztejn, DanielCheang, MaryBaloglu, ErkanSenapedis, WilliamShacham, SharonKauffman, MichaelMai, Sabine
- [39] Combined Targeting of BcI-2 and XPO1 Overcomes Acquired Resistance to Tyrosine Kinase Inhibitors in the FLT3-ITD/TKD Double Mutant AMLBLOOD, 2018, 132Tabe, YokoYamatani, KotokoYang, HaeunSaito, KaoriMurakami-Tonami, YukoSuzuki, KoyaZhang, WeiguoKinjo, SonokoIkeo, KazuhoHosoya, MasakiMogushi, KaoruYamaguchi, ShigeoHarada, HironoriMiida, TakashiShah, NeilKonopleva, Marina Y.Hayashizaki, YoshihideAndreeff, Michael
- [40] Phase 1/2 trial of the XPO1 inhibitor selinexor in combination with docetaxel in previously treated, advanced KRAS mutant non-small cell lung cancer (NSCLC)JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)von Itzstein, Mitchell S.Burns, Timothy F.Dowell, JonathanHorn, LeoraCamidge, David RossYork, Sally J.Eaton, Keith D.Walker, Christopher JamesZhang, SongGerber, David E.